Structure Therapeutics Inc.
Government Contracts & Awards
No recent government contracts or awards found.
Proprietary Tech & Patents
No patents found in our USPTO sample (a narrow, keyword-clustered feed of recent grants in strategic tech sectors — not a comprehensive patent database).
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Structure Therapeutics CEO: 'We’re going to see an evolution' in weight loss market
At the American Diabetes Association’s 2026 Scientific Sessions, CNBC’s Angelica Peebles sat down with Structure Therapeutics CEO Ray Stevens who discusses his “best in class” oral weight loss pill that is expected to come to market by 2029.
Monashee Scales Back Its Bet on Structure Therapeutics
This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity.
Congressional Trades in $GPCR
No disclosed congressional trades found in $GPCR.
Insider Trades (Form 4)
Lin Xichen
Lin Xichen
Lin Xichen
FMR LLC
Lin Xichen
Lin Xichen
Key People
FMR LLC
10% Owner
Lin Xichen
CHIEF SCIENTIFIC OFFICER
Political Giving
No disclosed PAC contributions found for this entity.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro